AzTrials
AzTrials

Feasibility of Measurement of a Neuromuscular Block at the m. TrapeziusNCT01849198

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

A study testing accelerometry m. trapezius and m. adductor pollicis in people with Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius, run by Kreiskrankenhaus Dormagen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Accelerometric Assessment of neuromuscular block during anaesthesia is routinely performed at the M. adductor pollicis. However, many operations require positioning of the patients with arms attached to the body. In these situations, the anaesthesiologist has no access to the m.adductor pollicis. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
accelerometry m. trapezius and m. adductor pollicis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteGermany
Study dates
Apr 2013to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing general anaesthesia with endotracheal intubation
  • weight 50-90 kg

Who cannot join

  • Pregnancy
  • allergy to one of the drugs used
  • risk of pulmonary aspiration
  • expected difficulties with endotracheal intubation
  • intake of drugs known to influence neuromuscular block
  • infection (CRP > 0,5 mg/dl, leukocyte count > 12000/µl)

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • KKH Dormagen

    Dormagen, 41540

Other trials in Germany

About this study

Accelerometric Assessment of neuromuscular block during anaesthesia is routinely performed at the M. adductor pollicis. However, many operations require positioning of the patients with arms attached to the body. In these situations, the anaesthesiologist has no access to the m.adductor pollicis.

In this study, a new position of accelerometry at the neck is evaluated: Stimulation of the n. accessorius with accelerometry of the m. trapezius.

Being tested
accelerometry m. trapezius and m. adductor pollicis
Keywords
accelerometry, neuromuscular block, m. trapezius

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • accelerometry m. trapezius and m. adductor pollicisDevice

Study groups in NCT01849198
Study groupRoleWhat they receive
Group trapeziusOtherAssessment of intubation conditions after onset of the neuromuscular block at the m. trapezius
Receives: Device: accelerometry m. trapezius and m. adductor pollicis
group adductor pollicisOtherassessment of intubation conditions after onset of the neuromuscular block at the m. adductor pollicis
Receives: Device: accelerometry m. trapezius and m. adductor pollicis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recovery to a train of four ratio of 0.9

    Comparison between time to recovery [s] to a train of four ratio of 0.9 between both groups

    Measured: 60 minutes

Secondary outcomes (1)
  1. onset of neuromuscular block

    Comparison of onset time [s] between both groups. Onset time is defined as decrease of T1 to < 5% of initial twitch height.

    Measured: 10 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 May 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionDec 2015
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01849198
Sponsor's protocol ID
NMMneck
Status last verified
Sep 2016
First submitted
29 Apr 2013
Last updated
7 Sep 2016
Results posted
No
Data monitoring committee
No

Publications

  • Soltesz S, Stark C, Noe KG, Anapolski M, Mencke T. Comparison of the trapezius and the adductor pollicis muscle as predictor of good intubating conditions: a randomized controlled trial. BMC Anesthesiol. 2017 Aug 17;17(1):106. doi: 10.1186/s12871-017-0401-8.

    PubMed 28818054
  • Soltesz S, Stark C, Noe KG, Anapolski M, Mencke T. Monitoring recovery from rocuronium-induced neuromuscular block using acceleromyography at the trapezius versus the adductor pollicis muscle: an observational trial. Can J Anaesth. 2016 Jun;63(6):709-17. doi: 10.1007/s12630-016-0609-y. Epub 2016 Feb 10.

    PubMed 26864194

Questions about this trial

What is this clinical trial studying?

A study testing accelerometry m. trapezius and m. adductor pollicis in people with Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius, run by Kreiskrankenhaus Dormagen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recovery to a train of four ratio of 0.9 (time frame: 60 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01849198, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2016; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in